Prothena Corporation plc (0Y3M.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 05:53PM BST
| Previous close | 21.99 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 23.07 - 23.44 |
| 52-week range | 23.07 - 79.15 |
| Volume | |
| Avg. volume | 345 |
| Market cap | 7.593M |
| Beta (5Y monthly) | 0.24 |
| PE ratio (TTM) | 0.17 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Earnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Investor's Business Daily
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
The Alzheimer's treatment space is heating up — and could soon leave Eli Lilly's embattled drug, donanemab, in the dust, experts say.
- Zacks
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
Per Biogen (BIIB)/Eisai, the delay in CHMP recommendation for lecanemab is entirely related to procedural reasons at the EMA and is not related to the companies' regulatory filing.
© 2024 Yahoo. All rights reserved.